# Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal

> **NCT03938285** · NA · UNKNOWN · sponsor: **Instituto Nacional de Cardiologia Ignacio Chavez** · enrollment: 12 (actual)

## Conditions studied

- Hemodiafiltration
- Chronic Kidney Disease Requiring Chronic Dialysis

## Interventions

- **OTHER:** Theranova 400 membrane
- **OTHER:** FxCordiax 120 membrane

## Key facts

- **NCT ID:** NCT03938285
- **Lead sponsor:** Instituto Nacional de Cardiologia Ignacio Chavez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-02
- **Primary completion:** 2019-06-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03938285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03938285, "Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03938285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*